Mercado global de medidores de glicose não invasivos – Tendências do setor e previsão para 2030

Análise e tamanho do mercado de medidores de glicose não invasivos

De acordo com a Organização Mundial de Saúde (OMS), existem atualmente aproximadamente 450 milhões de casos de diabetes em todo o mundo, com um aumento potencial para 700 milhões até 2045, com um aumento para 39,7 milhões até 2030 e 60,6 milhões até 2060 só nos Estados Unidos. Mais de 90% dos diabéticos são do tipo 2, e a Federação Internacional de Diabetes prevê que a proporção da população mundial afectada pela diabetes aumente acentuadamente, tal como o número de diabéticos.

A Data Bridge Market Research analisa que o mercado dos medidores de glicose não invasivos, que foi de 165,41 milhões de dólares em 2022, deverá atingir os 321,22 milhões de dólares até 2030, com um CAGR de 8,65% durante o período de previsão de 2023 a 2030. Além do conhecimento sobre cenários de mercado, tais como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análise especializada aprofundada, epidemiologia de doentes, análise de pipeline, análise de preços e enquadramento regulamentar.

Âmbito e segmentação do mercado de medidores de glicose não invasivos

Market Definition

Non-Invasive Glucose Meters measure the amount of glucose in the blood. In the case of diabetic patients, glucose level information is critical. Glucose monitoring provides information for diabetic management and the effect of diabetic medication on the glucose level, allowing you to determine whether your blood glucose level is high or low.

Global Non-Invasive Glucose Meter Market Dynamics

Drivers

• Technological advancements will bolster the growth

Emerging technologies in smart insulin pens are expected to drive the global non-invasive glucose meter market during the forecast period. The iSenz adaptor for smart insulin pens is used to detect insulin levels. It provides injection angles for diabetic injection site optimization. Easylog is an adaptor for insulin pens that are linked to the internet. It gives patients the proper dosage and improved comfort to manage chronic illnesses such as diabetes. InsulCheck is a cap that fits insulin pens and includes a sensor to monitor temperature and consumption. And these are just a few examples of smart insulin pens accelerating market growth.

• Integration of monitoring and therapeutic features

Smart insulin pens have numerous advantages for diabetes management. These pens have extra features that make remembering the last insulin dose easier. Daily insulin injections with a syringe and needle are difficult and unpleasant. More people are using their smartphones and the internet to track records because of advancements in device communication technology which drives the market growth.

Opportunities

• Integration of data analytics and artificial intelligence

Big data analytics and AI are revolutionizing digital diabetes management. The market is expected to grow exponentially as new efficient digital diabetes management technologies become available, allowing for better diabetes control. With the increased use and growth of big data analytics, healthcare professionals and patients will have access to real-time structured and unstructured data.

Furthermore, AI-powered digital diabetes management devices aid in providing tailored hypoglycemic control solutions to patients. The device was designed to offer patients personalized insights into the glucose level response based on food intake, insulin dosage, and daily routines. As a result, introducing such novel and promising technologies in the field of non-invasive glucose meters will boost the market growth.

Restraints/Challenges

• Risks associated with non-invasive blood glucose monitoring devices

Non-invasive blood glucose monitoring devices are the next step in continuous glucose monitoring (CGM) devices for a variety of reasons, including wearer comfort, which is a challenging factor for the non-invasive glucose metre market. However, disease-free glucose monitoring devices are based on a variety of technologies that detect biological features of the skin or organic fluids. The accuracy provided by these product types does not come close to that of CGM devices under uncontrolled conditions, which is a restraint on the growth of the non-invasive glucose metre market globally during the forecast period.

This non-invasive glucose meter market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the non-invasive glucose meter market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Non-Invasive Glucose Meter Market

The COVID-19 pandemic has accelerated the growth of the non-invasive glucose metre market. Blood glucose control became critical for patients admitted to hospitals with severe lung infections. The medications used to treat the disease caused a significant change in the patient's blood glucose levels. Furthermore, people with diabetes who were diagnosed with COVID-19 were admitted to critical care, according to the Centers for Disease Control and Prevention. As a result, the demand for non-invasive glucose metres has rise steeply.

Recent developments

• In March 2022, Dexcom Inc. announced that the FDA had granted Dexcom continuous glucose monitor (CGM) use in hospitals Breakthrough Device Designation. This cutting-edge compact device consists of a small wearable sensor and transmitter that provides real-time glucose readings, warnings, and alarms to detect potentially low or high glucose levels.

Global Non-Invasive Glucose Meter Market Scope

The non-invasive glucose meter market is segmented on the basis of component, site, application, and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Component

• Measuring Device
• Monitoring patches
• Continuous monitoring sensors
• Smart lenses
• Smart watches
• Transmitter and Software/ App

 Site

• Arm/ Wrist
• Ear Lobe
• Forefinger and Thumb and Cornea/ Eye

 Application

• Intensive Insulin Therapy
• Hypoglycemia and Diabetic Foot Ulcer Tracking

 End-User

• Home Healthcare Setting
• Healthcare Provider
• Research Institutes

Non-Invasive Glucose Meter Market Regional Analysis/Insights

The non-invasive glucose meter market is analysed and market size insights and trends are provided by country, component, site, application, and end use as referenced above.

The countries covered in the non-invasive glucose meter market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the non-invasive glucose meter market because of the increased healthcare spending.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of increased glucose monitoring penetration, increased patient awareness, and rising per capita healthcare expenditure in this region

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

O mercado de medidores de glicose não invasivos também fornece análises de mercado detalhadas para o crescimento de cada país nos gastos de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado de medidores de glicose não invasivos, impacto da tecnologia utilizando curvas de linha de vida e mudanças nos cenários regulamentares de saúde e o seu impacto no mercado de medidores de glicose não invasivos. Os dados estão disponíveis para o período histórico 2011-2021.

Análise do cenário competitivo e da quota de mercado do medidor de glicose não invasivo

O panorama competitivo do mercado de medidores de glicose não invasivos fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados fornecidos acima estão apenas relacionados com o foco das empresas relacionado com o mercado de medidores de glicose não invasivos.

Alguns dos principais players que operam no mercado dos medidores de glicose não invasivos são:

• Abbott (EUA)
• PHC Holdings Corporation (Japão)
• WellDoc, Inc (Índia)
• Sanofi (França)
• Dexcom, Inc (EUA)
• DarioHealth Corp.
• Medtronic (Irlanda)
• B. Braun SE (Alemanha)
• F. Hoffmann-La Roche Ltd (Suíça)
• Insulet Corporation (EUA)
• Ascensia Diabetes Care Holdings AG (Suíça)
• Piscina de maré (EUA)
• Medtronic (Irlanda)
• Cuidados tandem para a diabetes (EUA)
• LifeScan (EUA)
• AgaMatrix (EUA)
• (EUA)
• DarioHealth (Israel)
• BD (EUA) 

SKU-59280